Treatment of Anorexia Nervosa-New Evidence-Based Guidelines.
anorexia nervosa
evidenced-based
guidelines
treatment
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
29 Jan 2019
29 Jan 2019
Historique:
received:
21
12
2018
revised:
20
01
2019
accepted:
28
01
2019
entrez:
1
2
2019
pubmed:
1
2
2019
medline:
1
2
2019
Statut:
epublish
Résumé
Anorexia nervosa is the most severe eating disorder; it has a protracted course of illness and the highest mortality rate among all psychiatric illnesses. It is characterised by a restriction of energy intake followed by substantial weight loss, which can culminate in cachexia and related medical consequences. Anorexia nervosa is associated with high personal and economic costs for sufferers, their relatives and society. Evidence-based practice guidelines aim to support all groups involved in the care of patients with anorexia nervosa by providing them with scientifically sound recommendations regarding diagnosis and treatment. The German S3-guideline for eating disorders has been recently revised. In this paper, the new guideline is presented and changes, in comparison with the original guideline published in 2011, are discussed. Further, the German guideline is compared to current international evidence-based guidelines for eating disorders. Many of the treatment recommendations made in the revised German guideline are consistent with existing international treatment guidelines. Although the available evidence has significantly improved in quality and amount since the original German guideline publication in 2011, further research investigating eating disorders in general, and specifically anorexia nervosa, is still needed.
Identifiants
pubmed: 30700054
pii: jcm8020153
doi: 10.3390/jcm8020153
pmc: PMC6406277
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Christina Barz-Stiftung, Association of German Academic Foundations
ID : N/A
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Lancet. 2000 Feb 26;355(9205):721-2
pubmed: 10703806
Aust N Z J Psychiatry. 2004 Sep;38(9):659-70
pubmed: 15324328
Am J Psychiatry. 2005 Apr;162(4):741-7
pubmed: 15800147
Z Arztl Fortbild Qualitatssich. 2007;101(2):89-95
pubmed: 17458353
Br J Psychiatry. 2009 Feb;194(2):168-74
pubmed: 19182181
Psychother Psychosom Med Psychol. 2009 Dec;59(12):454-63; quiz 464-6
pubmed: 19921600
Psychother Psychosom Med Psychol. 2011 Jul;61(7):293-4
pubmed: 21755486
World J Biol Psychiatry. 2011 Sep;12(6):400-43
pubmed: 21961502
Int J Eat Disord. 2012 May;45(4):476-91
pubmed: 22294558
Psychiatry Res. 2012 Dec 30;200(2-3):518-23
pubmed: 22657951
Lancet. 2014 Jan 11;383(9912):127-37
pubmed: 24131861
Lancet. 2014 Apr 5;383(9924):1222-9
pubmed: 24439238
JAMA Psychiatry. 2014 Nov;71(11):1279-86
pubmed: 25250660
J Consult Clin Psychol. 2015 Aug;83(4):796-807
pubmed: 25984803
Eur Eat Disord Rev. 2015 Jul;23(4):318-26
pubmed: 26059633
Lancet Psychiatry. 2015 Dec;2(12):1099-111
pubmed: 26514083
Nat Rev Dis Primers. 2015 Nov 26;1:15074
pubmed: 27189821
J Am Acad Child Adolesc Psychiatry. 2016 Aug;55(8):683-92
pubmed: 27453082
Psychol Med. 2016 Dec;46(16):3291-3301
pubmed: 27609525
BMC Psychiatry. 2016 Nov 24;16(1):422
pubmed: 27881106
Curr Opin Psychiatry. 2017 Nov;30(6):423-437
pubmed: 28777107
Front Psychiatry. 2018 May 01;9:158
pubmed: 29765338
Psychol Med. 2019 Apr;49(6):898-910
pubmed: 30514412
J Consult Clin Psychol. 2019 Jan;87(1):91-105
pubmed: 30570304
Psychol Med. 1995 Jan;25(1):143-56
pubmed: 7792349
Int J Eat Disord. 1997 Dec;22(4):339-60
pubmed: 9356884